It is estimated that more than 600,000 knee replacement surgeries are performed each year in the United States. Doctors recommend knee replacement for patients with severe joint damage, pain, limited mobility, and those who do not respond well to traditional treatment methods and medications. Surgery however, does not come without risks. 
Potential Risks Associated with Knee Replacement Surgery
Though knee replacement surgery may lead to improved mobility and a reduction in pain, the risks of surgery are not inconsequential. Potential risks of knee replacement surgery may include infection, blood clot, heart attack, stroke, and nerve damage. If the artificial knee becomes infected, a second surgery to remove the infected components is indicated followed by a third surgery to perform another knee replacement. In addition, the artificial joint may fail, or wear out eventually.
Stem Cell Therapy: A Potential Treatment to Avoid Knee Replacement
Personalized Stem Cells (PSC), a human adipose-derived stem cell company, is currently conducting an FDA-approved stem cell clinical trial for the treatment of osteoarthritis in the knee. The stem cells are extracted and concentrated from a person’s own fat and then injected back into the affected knee. Stem cells from related products have been shown to reduce inflammation and pain as well as to regenerate joint tissues. PSC’s clinical trial may provide data to help determine if treatment with stem cells may help patients avoid knee replacement surgery.
PSC is working within the FDA cell therapy regulations to provide stem cell recipients with consistently manufactured, quality tested cells, as well as clinical trial and manufacturing oversite for safety and efficacy. Though we are not currently soliciting patients for participation in the ongoing knee trial, we plan to launch additional clinical trials in the future. For information on future clinical trials, contact us here.